Tijaabada ELARA, sinjiyeynta follicular, Kymiah, NCT03568461, Novartis, Shirkadda Novartis Pharmaceuticals Corporation waxay ku saleysantahay Maraykanka, Tisagenlecleucel
Tisagenlecleucel waxa u ansixisay FDA dib u soo noqoshada ama limfoma follicular refractory
Juun 2022: Laba ama in ka badan oo daawaynta habaysan ka dib, FDA waxay siisay tisagenlecleucel (Kymriah, Novartis Pharmaceuticals Corporation) oo dadajisay oggolaanshaha bukaanada qaangaarka ah ee dib u soo noqday ama dib u soo noqday follicular lymphoma (FL).T.
Acalabrutunib, Avelumab, Daaweynta CART, Dabrafanib, Kymiah, Dawooyinka ugu dambeeyay, Midostaurin, Niraparib, Pembrolizumab, Tecartus, Tisagenlecleucel, Trametinib, USFDA
Daawooyinka ugu dambeeyay ee daaweynta kansarka
Julaay 2021: Eeg dawooyinkii ugu dambeeyay ee daawaynta kansarka. Sannad kasta, ka dib marka la eego tijaabooyinka iyo arrimo kale oo muhiim ah, USFDA waxay ansixisay daawooyinka, sidaas awgeed bukaannada kansarka waxay hadda rumaysan karaan in daawadu aad u dhowdahay. ..